SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
Study sponsor: Aldeyra Therapeutics, Inc. · ALDX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2019-04-19Actual
Enrollment · participants123Actual
Source updated2025-02-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.